Protalix BioTherapeutics
PLX
#8996
Rank
$0.19 B
Marketcap
$2.44
Share price
2.95%
Change (1 day)
71.83%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): $20.8 Million USD

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are $76.38 Million USD. In 2025 the company made an earning of -$4.26 Million USD a decrease over its 2024 earnings that were of $5.21 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $20.8 M-588.82%
2025 -$4.26 Million-181.6%
2024 $5.21 M-55.62%
2023 $11.75 M-199.05%
2022 -$11.87 Million-40.38%
2021 -$19.91 Million-732.31%
2020 $3.14 M-130.53%
2019 -$10.31 Million189.85%
2018 -$3.56 Million-95.29%
2017 -$75.55 Million308.12%
2016 -$18.52 Million-32.37%
2015 -$27.38 Million10.11%
2014 -$24.86 Million-7.59%
2013 -$26.9 Million
2011 -$31.15 Million-19.39%
2010 -$38.65 Million20.87%
2009 -$31.97 Million32.26%
2008 -$24.18 Million-5.46%
2007 -$25.57 Million
2004 -$0.17 Million12.35%
2003 -$0.15 Million-11.1%
2002 -$0.17 Million-57.03%
2001 -$0.39 Million1.03%
2000 -$0.39 Million-53.22%
1999 -$0.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.59 B 50,808.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$0.79 B 3,739.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$0.19 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$2.27 B 10,816.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel